2019 annual financial data

Rigel Pharmaceuticals 2019 Financial results

Direct answer

Revenue was 59,288,000 USD.

Operating income was -69,091,000 USD and net income was -66,546,000 USD.
Operating cash flow was -41,510,000 USD.

Get free Rigel Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
59,288,000 USD
Operating income
-69,091,000 USD
Net income
-66,546,000 USD
Operating cash flow
-41,510,000 USD